Tissue engineering strategies have been showing promising early results in articular cartilage lesions repair. Hydrogels based on natural origin polymers as chitosan glycerol-phosphate (CGP) thermosensitive formulation that can be implanted in a minimal invasive manner, represent a great promise as injectable scaffold choice for cartilage tissue engineering, but it lacks in mechanical properties. A different formulation, from which a firm texture gels results is, therefore, desirable. In this work we first aim to investigate the suitability of CGP to produce an injectable thermosensitive, pH-dependent solution, when combined with increasing concentrations of starch: 0.5% (I), 1% (II), and 1.5% (III). The data collected from the rheological measurements showed that the addition of starch to the CGP did not alter the transition temperature and confirmed the heating inducing gelation of all solutions, supporting the ability of these novel formulations to be applied as minimal invasive systems. The evaluation of the dynamic mechanical analysis of the hydrogels showed an increase in the storage modulus within increasing starch concentration, clearly demonstrating that best viscoelastic properties were obtained with the novel chitosan-starch based solution. The incorporation of starch also improved the degradation profile. All materials showed to be biocompatible through the cytotoxicity screening in vitro. These data suggested the potential of novel thermo-responsive chitosan-starch hydrogels to be used as injectable vehicles for cell delivery in cartilage tissue engineering applications. In a second phase, the potential of chitosan-b-glycerophosphate (CGP) and chitosan-bglycerophosphate-1% starch (CST) hydrogels to induce chondrocytic differentiation and cartilage matrix accumulation were evaluated, as well as the influence of starch in the chondrogenesis of encapsulated adipose derived stromal (ADSC) cells. The ADSC were homogeneously encapsulated, remained viable, proliferated, and maintained the expression of typical chondrogenic markers genes, and deposited cartilage ECM molecules. Improved results were obtained within the novel CST constructs. The overall data suggest that chitosan-b-glycerophosphate-starch hydrogels could be considered for chondrogenic differentiation of adipose derived stromal cells for cartilage-engineered regeneration using minimal invasive techniques.

Recent advances in tissue engineering and regenerative medicine fields can offer alternative solutions to the existing techniques for cartilage repair. In this context, a variety of materials has been proposed, and the injectable hydrogels are among the most promising alternatives. The aim of this work is to explore the ability of poly(N-isopropylacrylamide)-g-methylcellulose (PNIPAAm-g-MC) thermoreversible hydrogel as a three-dimensional support for cell encapsulation toward the regeneration of articular cartilage through a tissue engineering approach. The PNIPAAm-g-MC copolymer was effectively obtained using ammonium-persulfate and N,N,N',N'-tetramethylethylenediamine as initiator as confirmed by Fourier transform infrared spectroscopy and (1) H NMR results. The copolymer showed to be temperature responsive, becoming a gel at temperatures above its lower critical solution temperature (~ 32 °C) while turning into a liquid below it. Results obtained from the MTS test showed that extracts of the hydrogel were clearly noncytotoxic to L929 fibroblast cells. ATDC5 cells, a murine chondrogenic cell line, were used as the in vitro model for this study; they were encapsulated at high cell density within the hydrogel and cultured for up to 28 days. PNIPAAm-g-MC did not affect the cell viability and proliferation, as indicated by both MTS and DNA assays. The results also revealed an increase in synthesis of glycosoaminoglycans within culture time measured by the dimethylmethylene blue quantification assay. These results suggest the viability of using PNIPAAm-g-MC thermoresponsive hydrogel as a three-dimensional scaffold for cartilage tissue engineering using minimal-invasive strategies.

No abstract